Try our Advanced Search for more refined results
BURLINGTON DRUG CO., INC. et al v. PFIZER INC. et al
Case Number:
3:12-cv-02389
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Baker & Hostetler
- Berger Montague
- Blank Rome
- Carella Byrne
- Cohen Milstein
- Cohn Lifland
- Connell Foley
- DeBenedictis & DeBenedictis
- Dilworth Paxson
- Duane Morris
- Ferraro Law Firm
- Garwin Gerstein
- Gerard Fox Law
- Glancy Prongay
- Grant & Eisenhofer
- Hach Rose Schirripa
- Hangley Aronchick
- Haug Partners
- Kenny Nachwalter
- Kirkland & Ellis
- Lite DePalma
- Marcus & Shapira
- Miller Shah LLP
- Napoli Shkolnik
- NastLaw
- Neal & Harwell
- Patunas Law
- Robbins Geller
- Saiber LLC
- Sauder Schelkopf
- Schnader Harrison
- Schoenefeld Law Firm LLC
- Seeger Weiss
- Shub & Johns
- Spiro Harrison
- Walsh Pizzi
- White & Case
Companies
- Cardinal Health Inc.
- CVS Health Corp.
- Daiichi Sankyo Co.
- Fraternal Order of Police
- Giant Eagle Inc.
- H‑E‑B LP
- International Brotherhood of Electrical Workers
- LifeWallet
- Meijer Inc.
- Pfizer Inc.
- Ranbaxy
- Rite Aid Corp.
- Rochester Drug Cooperative Inc.
- Safeway Inc.
- Supervalu Inc.
- The Kroger Co.
- Viatris Inc.
Sectors & Industries:
-
September 12, 2014
Pfizer Sheds Lipitor Buyers' Class Action In Antitrust MDL
A New Jersey federal judge on Friday dismissed an antitrust suit in multidistrict litigation challenging a purportedly anti-competitive patent infringement settlement between Pfizer Inc. and Ranbaxy Laboratories Ltd. over Lipitor, ruling a proposed class of pharmaceutical wholesalers and retailers failed to state a claim.
-
November 19, 2013
Daiichi Sankyo Escapes Antitrust MDL Over Generic Lipitor
A New Jersey federal judge on Monday released Daiichi Sankyo Inc. from multidistrict antitrust litigation challenging a patent infringement settlement between Pfizer Inc. and Ranbaxy Laboratories Inc. over Pfizer's cholesterol drug Lipitor, in which Daiichi Sankyo claimed it had no involvement.
-
January 17, 2013
Cohen Milstein Survives DQ Bid In Lipitor MDL
Cohen Milstein Sellers & Toll PLLC will remain in multidistrict litigation over Pfizer Inc.'s alleged efforts to keep a generic form of Lipitor off the market after a New Jersey federal judge on Thursday rebuffed Blue Cross Blue Shield of Louisiana's bid to oust the firm.
-
November 19, 2012
Pfizer Says Lipitor Buyers Can't Bring Antitrust Challenge
Pfizer Inc. sought Friday to end a class action concerning its purportedly anti-competitive settlement resolving patent litigation over Ranbaxy Inc.'s generic challenge to Pfizer's cholesterol drug Lipitor, telling a New Jersey federal court that the drug retailer plaintiffs lack standing to pursue the case.
-
October 25, 2012
Pfizer, Ranbaxy Can't Pause Lipitor Pay-For-Delay Suit
A New Jersey judge has refused to halt multidistrict antitrust litigation challenging patent infringement settlements Pfizer Inc. reached over its cholesterol treatment Lipitor, ruling that waiting for the U.S. Supreme Court to take and decide similar suits over pay-for-delay deals would stall the case too long.
- ← Previous
- 1
- 2
- 3
- Next →